Palmer Knight Co Boosts Stock Holdings in Elevance Health, Inc. $ELV

Key Points

• Palmer Knight Co boosted its stake in Elevance Health by 98.9% in Q4, adding 10,162 shares to hold 20,432 shares valued at about $7.16 million, which represents 3.8% of the firm's portfolio and its 15th-largest position.
• Elevance beat expectations with quarterly EPS of $12.58 and revenue of $49.49 billion, provided FY2026 guidance of about $19.85 EPS, and announced a quarterly dividend of $1.72 ($6.88 annualized, ~1.9% yield).
• Analysts give the stock a consensus rating of "Moderate Buy" with a consensus price target of $384.58, while recent analyst targets range from $350 (Mizuho) up to $425 (Wolfe) and several firms maintain buy/overweight ratings.

Palmer Knight Co grew its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 98.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 20,432 shares of the company's stock after purchasing an additional 10,162 shares during the quarter. Elevance Health makes up 3.8% of Palmer Knight Co's portfolio, making the stock its 15th biggest position. Palmer Knight Co's holdings in Elevance Health were worth $7,162,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of ELV. Physician Wealth Advisors Inc. increased its holdings in Elevance Health by 331.6% during the third quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company's stock valued at $26,000 after buying an additional 63 shares during the period. Activest Wealth Management lifted its holdings in Elevance Health by 66.7% during the third quarter. Activest Wealth Management now owns 85 shares of the company's stock worth $27,000 after buying an additional 34 shares during the period. Rossby Financial LCC boosted its position in Elevance Health by 110.0% during the 3rd quarter. Rossby Financial LCC now owns 84 shares of the company's stock valued at $28,000 after acquiring an additional 44 shares in the last quarter. Motco boosted its position in Elevance Health by 334.8% during the 3rd quarter. Motco now owns 100 shares of the company's stock valued at $32,000 after acquiring an additional 77 shares in the last quarter. Finally, ORG Partners LLC increased its holdings in shares of Elevance Health by 120.4% in the 4th quarter. ORG Partners LLC now owns 108 shares of the company's stock valued at $38,000 after acquiring an additional 59 shares during the period. Hedge funds and other institutional investors own 89.24% of the company's stock.

Analysts Set New Price Targets

Several research firms have recently commented on ELV. Mizuho reduced their price target on Elevance Health from $413.00 to $350.00 and set an "outperform" rating for the company in a research report on Wednesday, March 11th. UBS Group set a $400.00 target price on Elevance Health in a research note on Thursday, January 29th. JPMorgan Chase & Co. boosted their target price on shares of Elevance Health from $397.00 to $411.00 and gave the stock an "overweight" rating in a report on Tuesday, April 28th. Guggenheim increased their price target on shares of Elevance Health from $396.00 to $399.00 and gave the company a "buy" rating in a research report on Friday, April 24th. Finally, Wolfe Research set a $425.00 price target on shares of Elevance Health and gave the company an "outperform" rating in a report on Thursday, January 8th. Thirteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $384.58.

Elevance Health Stock Down 0.8%

Elevance Health stock opened at $369.06 on Wednesday. Elevance Health, Inc. has a 1-year low of $273.71 and a 1-year high of $424.24. The business has a fifty day moving average price of $311.21 and a 200-day moving average price of $331.78. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.48 and a quick ratio of 1.48. The stock has a market capitalization of $80.15 billion, a price-to-earnings ratio of 15.70, a PEG ratio of 2.12 and a beta of 0.66.

Elevance Health (NYSE:ELV - Get Free Report) last announced its earnings results on Wednesday, April 22nd. The company reported $12.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.74 by $1.84. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The company had revenue of $49.49 billion for the quarter, compared to analyst estimates of $48.21 billion. During the same period in the prior year, the company posted $11.97 EPS. The firm's quarterly revenue was up 1.5% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Equities research analysts forecast that Elevance Health, Inc. will post 26.79 EPS for the current fiscal year.

Elevance Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be issued a dividend of $1.72 per share. The ex-dividend date is Wednesday, June 10th. This represents a $6.88 annualized dividend and a dividend yield of 1.9%. Elevance Health's dividend payout ratio is 29.26%.

Elevance Health Company Profile

Elevance Health, Inc NYSE: ELV is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery.

Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.

Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.